Revisiting the use of recombinant erythropoietin in myelodysplastic syndromes.
Musto
Pellegrino
P
Unit of Hematology and Stem Cell Transplantation IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo, Italy.
D004359:Drug Therapy, Combination; D004921:Erythropoietin / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D011994:Recombinant Proteins; D016896:Treatment Outcome
D006133:Growth Substances; D011994:Recombinant Proteins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor